Protocols
2 protocol(s) meet the specified criteria
Drug: ABIRATERONE
Protocol No.TitleStatus
AFT-19A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerOpen
C16-168A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair DefectsOpen